| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |